Mode
Text Size
Log in / Sign up
N/A N=128 Randomized Health Services Research

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Acute Myeloid Leukemia · Brain Glioblastoma · Estrogen Receptor Negative · Extensive Stage Small Cell Lung Carcinoma · Head and Neck Carcinoma

Enrolled (actual)
128
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcome: Primary: Number of Emergency Department Visits (Chart Review) — 1.33; 0.41 visits

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Best Practice (Other); Laboratory Biomarker Analysis (Other); Supportive Care (Procedure); Survey Administration (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Stanford University
Primary completion
Nov 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Emergency Department Visits (Chart Review)
1.33; 0.41
PRIMARY
Number of Hospitalization Visits (Chart Review)
0.91; 0.44
SECONDARY
Change in Patient Satisfaction With Care and Decision Making Among Patients Undergoing Health Care Coach Support as Assessed by Consumer Assessment of Healthcare Providers and Systems-G and Patient Satisfaction With Decision Scale
47; 50; 40; 44; 29; 28
SECONDARY
Change in Patient Satisfaction With Care Among Patients Undergoing Health Care Coach Support as Assessed by Consumer Assessment of Healthcare Providers and Systems-G.
22; 22; 21; 34; 15; 17
SECONDARY
Mean Emergency Department Visits (Chart Review)
2.02; 0.92
SECONDARY
Number of People With Emergency Department Visit (Chart Review)
4; 0
SECONDARY
Hospitalization Visits (Chart Review)
1.63; 0.82
SECONDARY
Number of Patients With Hospital Use (Chart Review)
3; 0
SECONDARY
Hospice Consult (Chart Review)
9; 16
SECONDARY
Hospice Consult (Chart Review)
9; 16
SECONDARY
Hospice Consult (Chart Review)
9; 16
SECONDARY
Palliative Care Consult (Chart Review)
17; 26
SECONDARY
Palliative Care Consult (Chart Review)
17; 26
SECONDARY
Palliative Care Consult (Chart Review)
17; 26

Summary

This randomized pilot clinical trial studies health care coach support in reducing acute care use and cost in patients with cancer. Health care coach support may help cancer patients to make decisions about their care that matches what is important to them with symptom management.

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosed patients for the following conditions
  • Colon cancer stage III and IV
  • Rectal cancer stage II, III, IV
  • Glioblastoma multiforme (brain) -- no stage
  • Non-small cell lung cancer stage IIIA, IIIB, IV
  • Small cell lung cancer, limited stage and extensive stage
  • Castration-resistant prostate cancer
  • Head and neck cancer stage III and IV
  • Gastric cancer stage III and IV
  • Esophageal cancer stage III and IV
  • Pancreatic cancer stage II, III, IV
  • Renal cell carcinoma, stage IV
  • Breast cancer, stage IV, if triple negative ER/PR/H2N negative or on systemic chemotherapy
  • Sarcoma, stage IV
  • Bladder carcinoma, stage IV
  • Acute myeloid leukemia
  • Melanoma, stage III and IV
  • Ovarian cancer, stage III and IV
  • High grade myelodysplastic syndrome (MDS)
  • Any patient with recurrent or progressive cancer
  • Patients must have the ability to understand and willingness to sign a written informed consent document
  • Patient must have ongoing oncologic needs and plan to receive all care at the study institution and not already be in hospice or home-care

Exclusion Criteria

  • Patients must have capacity to consent
  • Pregnant patients are excluded
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03154190). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search